Cheng A, Heine R, Del Prato S, Green J, Thieu V, Zeytinoglu M
Diabetes Obes Metab. 2025; 27(4):1708-1718.
PMID: 39871817
PMC: 11885087.
DOI: 10.1111/dom.16206.
Shubrook J
Fed Pract. 2025; 41(Suppl 6):S47-S52.
PMID: 39839064
PMC: 11745467.
DOI: 10.12788/fp.0536.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H
Diabetol Int. 2024; 15(3):327-345.
PMID: 39101173
PMC: 11291844.
DOI: 10.1007/s13340-024-00723-8.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H
J Diabetes Investig. 2024; 15(9):1326-1342.
PMID: 38988282
PMC: 11363114.
DOI: 10.1111/jdi.14202.
Rodriguez P, San Martin V, Pantalone K
Diabetes Ther. 2024; 15(3):567-583.
PMID: 38272993
PMC: 10942954.
DOI: 10.1007/s13300-024-01530-9.
Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes.
Tsai Y, Kuo T, Lin M, Shen F, Lin Y
J Diabetes Investig. 2023; 15(2):227-236.
PMID: 37882416
PMC: 10804897.
DOI: 10.1111/jdi.14102.
Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?.
King A, Miller E
Clin Diabetes. 2023; 41(2):226-238.
PMID: 37092151
PMC: 10115618.
DOI: 10.2337/cd22-0027.
Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies.
Reddy S, Wu C, Jose A, Hsieh J, Rautela S
Clin Diabetes. 2023; .
PMID: 36920750
PMC: 10338274.
DOI: 10.2337/cd22-0128.
Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes.
Musacchio N, Zilich R, Ponzani P, Guaita G, Giorda C, Heidbreder R
J Diabetes. 2023; 15(3):224-236.
PMID: 36889912
PMC: 10036260.
DOI: 10.1111/1753-0407.13361.
A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H
Diabetol Int. 2023; 14(1):1-14.
PMID: 36636161
PMC: 9829926.
DOI: 10.1007/s13340-022-00605-x.
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H
J Diabetes Investig. 2022; 14(1):151-164.
PMID: 36562245
PMC: 9807160.
DOI: 10.1111/jdi.13960.
Prevalence and predictors of clinical inertia in patients with type 2 diabetes who were treated with a single oral antidiabetic drug.
Suzuki R, Kazumori K, Usui T, Shinohara M
J Diabetes Investig. 2022; 14(1):81-91.
PMID: 36229998
PMC: 9807146.
DOI: 10.1111/jdi.13923.
Time to Treatment Intensification to Reduce Diabetes-Related Complications: A Post Hoc Study.
Kaewbut P, Kosachunhanun N, Phrommintikul A, Chinwong D, Hall J, Chinwong S
Healthcare (Basel). 2022; 10(9).
PMID: 36141285
PMC: 9498838.
DOI: 10.3390/healthcare10091673.
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes.
Philis-Tsimikas A, Bajaj H, Begtrup K, Cailleteau R, Gowda A, Lingvay I
Diabetes Obes Metab. 2022; 25(2):331-341.
PMID: 36106652
PMC: 10092674.
DOI: 10.1111/dom.14871.
Evaluation of a Pharmacist-Managed Medication Adjustment Clinic Within an Academic Endocrinology Practice.
Schaefer M, Naseman K, Schadler A
Diabetes Spectr. 2022; 35(3):377-383.
PMID: 36082017
PMC: 9396724.
DOI: 10.2337/ds21-0060.
Treatment-Related Attributes of Diabetes Therapies and How People with Type 2 Diabetes Report Their Impact on Indicators of Medication-Taking Behaviors.
Sims T, Boye K, Robinson S, Kennedy-Martin T
Patient Prefer Adherence. 2022; 16:1919-1939.
PMID: 35958887
PMC: 9359496.
DOI: 10.2147/PPA.S367046.
The Association of Vitamin K2 Level with the Glycaemic Status in Type 2 Diabetic Patients: A Case-Control Study.
Helmy M, Elsaid N, Gwad M
Indian J Endocrinol Metab. 2022; 26(1):87-92.
PMID: 35662764
PMC: 9162250.
DOI: 10.4103/ijem.ijem_470_21.
Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro).
Bala C, Cerghizan A, Mihai B, Moise M, Guja C
BMJ Open. 2022; 12(5):e060852.
PMID: 35623748
PMC: 9150149.
DOI: 10.1136/bmjopen-2022-060852.
Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus.
Pleus S, Freckmann G, Schauer S, Heinemann L, Ziegler R, Ji L
Diabetes Ther. 2022; 13(5):829-846.
PMID: 35416589
PMC: 9076772.
DOI: 10.1007/s13300-022-01254-8.
Effect of Clinical Inertia on Diabetes Complications among Individuals with Type 2 Diabetes: A Retrospective Cohort Study.
Kaewbut P, Kosachunhanun N, Phrommintikul A, Chinwong D, Hall J, Chinwong S
Medicina (Kaunas). 2022; 58(1).
PMID: 35056371
PMC: 8780665.
DOI: 10.3390/medicina58010063.
